Atheroembolic Renal Disease

Slide 1 · Atheroembolic

Renal Disease

Cholesterol-crystal embolization of intrarenal arteries

Renal vascular pathology • mechanism, morphology and clinical interpretation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define the embolic lesion and identify its arterial source.

Trace atheromatous debris from the aorta or renal artery into the kidney.

Recognize cholesterol clefts and the relevant vascular compartments.

Relate embolic burden and baseline renal function to clinical injury.

Separate atheroembolism from stenosis, infarction and microangiopathy.

Slide 3 · The defining lesion is intravascular

Atheromatous debris embolizes into intrarenal arteries.

The source is an atherosclerotic plaque, not a primary glomerular process.

An arterial lumen contains cholesterol-crystal–rich embolic material.

Clinical significance depends on the embolic burden and renal reserve.

Slide 4 · Embolization is not the same as stenosis

Atheroembolic disease

Atherosclerotic renal artery stenosis

Detached plaque fragments travel downstream

Plaque narrows a major renal artery in situ

Arcuate/interlobular arterial lumens may contain crystals

Persistent renal hypoperfusion is the main consequence

Acute injury possible after an arterial procedure

Chronic ischemia / renovascular hypertension can result

Slide 5 · Place in renal vascular pathology

Renal vascular diseases

Large-artery narrowing / ischemia

Cholesterol plaque-fragment embolization

Small-vessel thrombotic microangiopathy

Slide 6 · The lesion begins in an atheroma

Original schematic: Longitudinal arterial section

Plaque core

Fibrous cap (lumen-facing surface)

Arterial lumen

Schematic, not a gross or microscopic specimen; Wall proportions are illustrative.

Slide 7 · What is inside the plaque core?

Extracellular cholesterol and cholesterol esters are major lipid constituents.

Foam-cell debris, necrotic material and variable thrombotic material coexist.

Crystalline cholesterol can be released if plaque integrity is disrupted.

In routine sections, cholesterol crystals often leave empty clefts.

Slide 8 · Atheroma develops in the arterial intima

Structural location

An atherosclerotic plaque is an intimal lesion.

A fibrous cap faces the arterial lumen.

Why it matters here

Plaque disruption exposes core debris to flowing blood.

The debris can reach renal arterial branches.

Slide 9 · Plaque rupture releases solid debris

Atheromatous plaque

Surface disruption

Debris enters bloodstream

Distal embolization

Slide 10 · Three major plaque complications differ

Complication

Immediate event

Renal implication

Stenosis

Progressive luminal narrowing

Reduced inflow / chronic ischemia

Thrombosis

Clot forms on disrupted plaque

Local arterial occlusion

Atheroembolism

Plaque material breaks free

Distal cholesterol-rich occlusion

Slide 11 · Embolus material is diagnostically informative

Cholesterol-rich debris

Derived from atheromatous plaque.

Angular empty cholesterol clefts can remain after processing.

Thrombotic embolus

Composed predominantly of intravascular clot.

Do not identify atheroembolism solely from an occluded lumen.

Slide 12 · The abdominal aorta is a major source

The aorta can shed plaque fragments into renal arterial flow.

Severe atherosclerosis provides the source lesion.

Proximity of the renal artery origins explains the renal pathway.

Aortic procedures are emphasized as triggering contexts.

Slide 13 · The renal artery itself can be the source

Renal arterial atheroma can generate embolic plaque fragments.

The debris moves from the source site to smaller intrarenal branches.

Thus the source plaque and embolus can lie within one vascular territory.

Slide 14 · Anatomic route of cholesterol emboli

Abdominal aorta

Renal artery

Intrarenal branches

Arcuate artery

Interlobular artery

Slide 15 · Intrarenal arteries: Where to look

Renal artery

Segmental / interlobar branches

Arcuate arteries

Interlobular arteries

Slide 16 · Emboli lodge distal to the parent plaque

Source plaque is disrupted

Debris follows arterial flow

Intrarenal lumen traps fragments

Downstream perfusion may suffer

Slide 17 · Focal lesions can be clinically silent

Atheroemboli are frequently of no significance.

A histologic embolus does not automatically imply renal failure.

A small embolic burden may produce little functional loss.

Clinical interpretation must incorporate baseline renal function.

Slide 18 · Severe atherosclerosis provides the substrate

Atheroembolic events occur in people with substantial plaque burden.

Atheromatous material must be available for detachment.

Arterial manipulation may disturb plaque and promote embolization.

Slide 19 · Older adults are the typical population

Clinical setting

Older adults with severe atherosclerosis.

Often vascular disease is already established.

Interpretive consequence

Underlying renal impairment may coexist.

A new embolic insult may unmask limited functional reserve.

Slide 20 · Abdominal aortic surgery is a recognized trigger

Atheromatous aorta

Surgical manipulation

Plaque fragments enter flow

Emboli reach intrarenal vessels

Slide 21 · Aortography is a recognized trigger

Robbins specifically lists aortography among precipitating exposures.

Catheter/instrument passage occurs in an atheromatous arterial environment.

Temporal association with a procedure raises suspicion but is not proof.

Slide 22 · Intra-aortic cannulation is a recognized trigger

Intra-aortic cannulation is explicitly named in the Robbins description.

Arterial instrumentation can be followed by atheromatous debris release.

Clinical injury is not inevitable after manipulation.

Slide 23 · Procedural exposure is a clue—not a criterion

What the exposure tells us

What it does not establish

A plausible moment of plaque disruption

That cholesterol emboli certainly formed

A mechanism connecting aorta and kidney

That renal dysfunction must occur

A reason to examine intrarenal vessels

That all postprocedural AKI is atheroembolic

Slide 24 · The source text does not require a procedure

“Especially after” does not mean “only after.”

Three interventional settings.

Its definition rests on embolized plaque fragments and cholesterol crystals.

No incidence or relative frequency of spontaneous events is provided.

Slide 25 · From plaque disruption to renal injury

Atheromatous source

Cholesterol-rich microemboli

Small intrarenal arteries

Variable renal consequence

Slide 26 · Embolic burden determines potential effect

Few emboli

Limited number of affected vascular lumens.

May have no clinically important consequence.

Numerous emboli

More vascular territories may be compromised.

An acute decrement in renal function becomes possible.

Slide 27 · Baseline renal function is the second variable

Preserved reserve

Some vessel loss may be tolerated.

Do not automatically equate emboli with renal failure.

Already compromised

Additional microvascular injury may precipitate AKI.

The same insult may carry a greater functional cost.

Slide 28 · An interaction—not a single threshold

Baseline × burden

Lower embolic burden

Higher embolic burden

Better baseline function

Often limited effect

Injury possible

Impaired baseline function

Injury possible

Greater concern for AKI

Conceptual interaction — no numerical risk thresholds implied.

Slide 29 · The spectrum of clinical consequence

No important effect

Renal injury

Acute renal failure

These are possible outcomes, not obligatory stages.

Slide 30 · Why absence of AKI does not refute emboli

Robbins explicitly says the emboli are frequently insignificant.

Functional measurements reflect summed nephron activity.

Sparse focal lesions may not produce a major global change.

Slide 31 · Why vulnerable kidneys may deteriorate

Preexisting renal impairment

New cholesterol embolization

Further loss of perfusion

Acute-on-chronic dysfunction

Slide 32 · The adverse event to recognize is AKI

Acute renal injury or failure can follow atheroembolization.

Older adults with compromised renal function.

The lesion is intrarenal arterial, not a primary tubular or immune deposit.

Do not ascribe every postprocedure creatinine increase to this mechanism.

Slide 33 · Histology anchors the diagnosis

Cholesterol crystals within an intrarenal arterial lumen are the signature.

Look for angular or rhomboid-appearing empty clefts.

Identify the vascular compartment surrounding the clefts.

Correlate the finding with atherosclerotic disease and exposure history.

Slide 34 · Vessel-wall versus luminal location matters

Original native PowerPoint schematic — NOT a photomicrograph

Arterial wall

Intrarenal vessel lumen

Empty angular cholesterol clefts

Slide 35 · Cholesterol clefts are processing footprints

Cholesterol crystals in plaque debris

Tissue fixation / routine processing

Lipid material removed

Angular empty clefts remain

Slide 36 · Why the clefts appear empty

Routine paraffin processing extracts much of the lipid.

The former crystal space persists as a sharply bounded empty profile.

A pale cleft is therefore indirect morphologic evidence of cholesterol.

Slide 37 · Rhomboid clefts are the textbook hallmark

Original native PowerPoint schematic — NOT a photomicrograph

Zoomed conceptual view of angular empty profiles

Rhomboid / angular clefts

Lipid has been removed during ordinary histologic processing.

Slide 38 · Arcuate and interlobular arteries are involved

Site identified

Emboli may occupy arcuate arteries.

Interlobular arteries are also described.

What a pathologist should report

The lesion is intraluminal.

Describe cholesterol clefts and the artery involved when identifiable.

Slide 39 · Do not confuse a cholesterol embolus with an atheroma

In situ atheroma

Downstream cholesterol embolus

Located in arterial intima

Located in an arterial lumen

Fibrous cap and lipid-rich core

Fragmented material with cholesterol clefts

Can generate stenosis or rupture

Represents material shed from a source plaque

Slide 40 · The histologic label requires context

First recognize the vessel, not merely an isolated clear space.

Next identify a group of characteristic angular intraluminal clefts.

Then assess whether their distribution fits downstream embolization.

Finally integrate history without replacing tissue evidence by assumption.

Slide 41 · Morphology cannot measure global renal function

What a section can show

A discrete embolus in a sampled artery.

Its luminal location and shape.

What a section cannot establish alone

Exact total embolic burden across both kidneys.

The clinical trajectory without laboratory context.

Slide 42 · Gross morphology: Avoid false specificity

The short Robbins atheroembolism section specifies the arterial microscopic lesion.

It does not describe a unique gross renal appearance for this disorder.

Gross wedge-shaped infarcts belong to the separate renal-infarct discussion.

Do not treat a generic pale kidney as diagnostic of cholesterol emboli.

Slide 43 · Three renal vascular mechanisms

Mechanism

Primary compartment

Signature result

Atheroembolism

Intrarenal arterial lumen

Cholesterol-crystal clefts

Renal artery stenosis

Large-artery intima/lumen

Chronic renal ischemia

TMA

Capillaries / arterioles

Microthrombi with endothelial injury

Slide 44 · Compare with atherosclerotic ischemic renal disease

Ischemic renal disease

Bilateral renal artery disease can cause chronic ischemia.

Hypertension may or may not accompany insufficiency.

Atheroembolic renal disease

Plaque fragments occlude downstream arteries.

The source emphasizes a variable, sometimes acute injury.

Slide 45 · Renal artery stenosis produces another pathway

Fixed plaque narrowing

Reduced renal artery inflow

Chronic ischemia

Renal insufficiency

Slide 46 · Renovascular hypertension is a different clue

Renal artery stenosis

An ischemic kidney can increase renin release.

Renin–angiotensin activation can elevate blood pressure.

Atheroembolism

A cholesterol cleft is the defining tissue finding.

Hypertension is not specified as the hallmark in the core paragraph.

Slide 47 · Renal infarction is not synonymous with microembolization

Renal infarct

Atheroembolic lesion

Commonly wedge-shaped ischemic necrosis

Arterial cholesterol-crystal microemboli

Often from thromboemboli of cardiac origin

From aorta or renal-artery atheroma

Can cause flank pain and hematuria

Can be silent or cause acute renal dysfunction

Slide 48 · Thrombotic microangiopathy has a different core lesion

TMA

Atheroembolic disease

Platelet-rich microthrombi

Cholesterol-rich plaque fragments

Glomerular capillaries / arterioles

Arcuate / interlobular arteries described

Syndromic hemolysis and thrombocytopenia

Not diagnostic features in the Robbins core definition

Slide 49 · Hypertensive nephrosclerosis: A different morphology

Nephrosclerosis

Arteriosclerosis and arteriolosclerosis.

Glomerulosclerosis with chronic tubulointerstitial scarring.

Atheroembolism

Specific luminal cholesterol clefts.

Potential acute worsening in compromised kidneys.

Slide 50 · A structured comparison of the differentials

Disorder

Typical mechanism

Most discriminating clue

Atheroembolism

Embolized plaque debris

Cholesterol clefts

Renal artery stenosis

Flow-limiting large-artery lesion

Fixed stenosis / chronic ischemia

Renal infarct

Arterial occlusion with tissue necrosis

Wedge-shaped infarction

TMA

Endothelial / platelet thrombotic injury

Microvascular thrombi

Slide 51 · Clinical suspicion is a chain of evidence

Older adult with atherosclerosis

Recent vascular manipulation

New renal dysfunction, if present

Seek vascular lesion evidence

Slide 52 · Three questions before attributing kidney injury

Is there a plausible atheromatous source?

Is the time course compatible with plaque disturbance?

Is the renal lesion demonstrated or otherwise convincingly supported?

Could fixed stenosis, infarction or TMA better explain the findings?

Slide 53 · Case 1 — an incidental tissue finding

HYPOTHETICAL CLINICOPATHOLOGIC VIGNETTE

An older adult with advanced atherosclerosis has an intrarenal arterial cholesterol embolus, but renal function remains stable.

QUESTION

Does this contradict Robbins?

Interpretation: No. Atheroemboli are frequently clinically insignificant; Burden and baseline function affect outcome.

Slide 54 · Case 2 — injury after aortic instrumentation

HYPOTHETICAL CLINICOPATHOLOGIC VIGNETTE

An older patient with reduced baseline renal function develops acute kidney injury after an aortic procedure.

QUESTION

What mechanism should enter the vascular differential?

Interpretation: Embolization of cholesterol-rich plaque material into intrarenal vessels. The time course alone is not proof.

Slide 55 · Case 3 — chronic narrowing without emboli

HYPOTHETICAL CLINICOPATHOLOGIC VIGNETTE

An older individual has bilateral atherosclerotic renal artery disease with gradual renal insufficiency.

QUESTION

Which mechanism better fits this description?

Interpretation: Chronic ischemic renal disease caused by large-artery stenosis, not necessarily cholesterol embolization.

Slide 56 · Case 4 — a wedge-shaped pale lesion

HYPOTHETICAL CLINICOPATHOLOGIC VIGNETTE

A renal specimen shows a sharply demarcated wedge-shaped zone of ischemic coagulative necrosis.

QUESTION

Which lesion must be distinguished from atheroembolism?

Interpretation: Renal infarction. A gross wedge is not the defining cholesterol-embolus lesion.

Slide 57 · Microscopic spotter — reason from location

Original native PowerPoint schematic — NOT a photomicrograph

Which compartment?

What are the angular empty profiles?

Which plaque source is plausible?

What establishes that this is an embolic lesion rather than an intimal atheroma?

Slide 58 · Causal exercise — connect the modifiers

HYPOTHETICAL CLINICOPATHOLOGIC VIGNETTE

Two patients receive a similar plausible embolic insult. One has preserved renal function; The other has substantial preexisting impairment.

QUESTION

What does the source predict about variability?

Interpretation: Outcome depends on both embolic number and preexisting renal function. No numeric risk estimate is given.

Slide 59 · Diagnostic pitfall: Procedure does not equal disease

Vascular instrumentation increases plausibility, not certainty.

An isolated renal injury can have other mechanisms.

Atheroembolic disease is defined by plaque-derived intravascular debris.

Clinical correlation should not replace morphologic discrimination.

Slide 60 · Diagnostic pitfall: All emboli are not identical

An embolus may consist of thrombus, atheromatous debris or other material.

The source and composition change the expected morphology.

Cholesterol-crystal clefts specifically support plaque-fragment embolization.

Slide 61 · Integrating source, lesion and consequence

Aortic / renal plaque

Distal cholesterol embolus

Intrarenal arterial clefts

Variable renal effect

Slide 62 · What should be retained?

Source: Severe aortic or renal arterial atherosclerosis.

Triggers: Abdominal aortic surgery, aortography and intra-aortic cannulation.

Microscopy: Cholesterol crystals leaving rhomboid clefts in intrarenal arteries.

Outcome: Often inconsequential, but AKI can occur with impaired reserve.

Slide 63 · Source, scope and image-access references

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 20, p. 855: Atheroembolic Renal Disease.

Robbins, Cotran & Kumar. Chapter 11: Atherosclerotic plaque composition, rupture and atheroembolism.

Robbins, Cotran & Kumar. Chapter 20: Renal artery stenosis, thrombotic microangiopathy and renal infarcts.

Open-licensed authentic renal biopsy micrographs: Wikimedia Commons, “Cholesterol embolus — intermed mag” (Nephron, CC BY-SA 3.0).

The linked Commons specimens are not embedded in this deck. Morphologic illustrations here are original editable schematics.